Zu "2407465-18-1" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Farletuzumab ecteribulin
Farletuzumab ecteribulin

Artikelnummer: TGM-T77908-5mg

Description: Farletuzumab ecteribulin (MORAb-202) is a highly cytotoxic antibody-drug conjugate (ADC) targeting human folate receptor alpha (FRA). This ADC comprises the humanized Farletuzumab antibody linked to Mal-PEG2-Val-Cit-PAB-eribulin through reduced interchain disulfide bonds, with an agent-to-antibody ratio...
Schlagworte: MORAb-202
Anwendung: Targets folate receptor (FOLR)
CAS 2407465-18-1
3.289,00 €
Bewerten
Farletuzumab Ecteribulin
Farletuzumab Ecteribulin

Artikelnummer: BPS-82929-1

Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0....
Schlagworte: Anti-FBP, Anti-FOLR, Anti-FOLR1, Anti-FR-alpha, Anti-KB cells FBP, Anti-Folate receptor 1, Anti-Folate receptor alpha,...
Anwendung: Cancer therapy target studies
Spezies-Reaktivität: human
CAS 2407465-18-1
MW: ~149 kD
ab 2.761,00 €
Bewerten